Clinical Trial Update: Isocyanate Antigens and T Cells That Cause Asthma

View source ↗

Summary

A Yale University-sponsored clinical trial examining isocyanate antigens and T cells that contribute to asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Yale University | Conditions: Asthma, Lung Diseases | Status: COMPLETED